• Pharma
  • Pharma
  • Pharma
  • Pharma
  • Pharma

Pharma

Cell-Based Assays World Industry and Market Prospects 2016-2026

Products, Services, Drug Discovery, ADME, Basic Research, Organoids, Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), High-Throughput Screening (HTS)

This 197-page report provides quantitative and qualitative information on 10-years revenue forecasts to 2026 at overall world market, submarkets and national market level presented in 130 charts and discussion.

Product code
DPH0002
Publication date
17/08/2016
Number of Pages
197

 

 

  • A new report by DART forecasts the world cell-based assay market will reach $6.9bn in 2020. That revenue forecast and others appear in Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME, Basic Research, Organoids, Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), High-Throughput Screening (HTS), published in August 2016.

    This 197-page report provides quantitative and qualitative information on 10-years revenue forecasts to 2026 at overall world market, submarkets and national market level presented in 130 charts and discussion.

    This report provides 10-years revenue forecasts to 2026 for these submarkets:

    • Products
    • Services
    • Drug discovery
    • ADME
    • Basic research

    Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME, Basic Research, Organoids, Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), High-Throughput Screening (HTS)

    Our work also shows individual revenue forecasts to 2026 for 11 national markets:

    • United States (US)
    • Japan
    • EU leaders – Germany, France, the UK, Italy and Spain (EU5)
    • BRIC nations – Brazil, Russia, India and China.

    Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME, Basic Research, Organoids, Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), High-Throughput Screening (HTS)

    This report discusses the competitive landscape in the cell-based assays market, which includes discussion on SWOT, STEP, Leading Companies, and M&A activities in this market.

    Find in this report, discussions on:

    • R&D activities – see progress, trends and prospects in cell-based assays research and development, finding technological, clinical and commercial possibilities

    • Companies, news and opinions:
      • 11 leading companies which produce cell-based assay products
      • 9 leading CROs and cell-based assay service suppliers
      • An interview conducted by DART with expert working in cell-based assays industry:
      • Analysis of what stimulates and restrains that industry and market - assess challenges and strengths there, helping you compete and gain advantages.

      Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME, Basic Research, Organoids, Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), High-Throughput Screening (HTS)


      This report also provides a separate chapter on Pricing, Reimbursement, Market Access and Regulations, providing insights on these national markets:

      • US
      • Japan
      • EU5
      • Emerging Markets
  • CHAPTER 1: EXECUTIVE SUMMARY

    1.1 Report Description
    1.2 Questions Answered by This Report
    1.3 What This Report Provides
    1.4 Research Methodology

    CHAPTER 2: CELL-BASED ASSAYS MARKET AND APPLICATION OVERVIEW

    2.1 New Drug Discovery and Development
    2.2 Drug Screening Assays
    2.3 The Different Assay Detection Methods and Technologies
    2.4 Cells Used in Cell-Based Assays
    2.5 Uses for Cell-Based Assays in Drug Discovery and Development

    CHAPTER 3: COMPETITIVE LANDSCAPE: CELL-BASED ASSAYS INDUSTRY

    3.1 STEP Analysis: Social, Technological, Economic and Political Factors Affecting the Cell-Based Assays Industry and Market.
    3.1.1 Social Factors
    3.1.2 Technological Factors
    3.1.3 Economic Factors
    3.1.4 Political Factors
    3.2 SWOT Analysis: Strengths, Weaknesses, Opportunities and Threats Affecting Cell-Based Assays Market
    3.2.1 Strengths Within the Cell-Based Assay Market
    3.2.2 Weaknesses Within the Cell-Based Assays Market
    3.2.3 Opportunities for the Cell-Based Assays Market
    3.2.4 Threats to the Cell-Based Assays Market
    3.3 Leading Companies in Cell-Based Assays Market: Product Suppliers, 2016
    3.3.1 Thermo Fisher Scientific
    3.3.1.1 ThermoFisher Scientific- Revenue Performance Analysis
    3.3.1.2 ThermoFisher’s Life Science Solutions Segment-Cell-Based Assay Products and Applications
    3.3.2 DiscoveRx
    3.3.2.1 DiscoveRx- Cell-Based Assay Platforms and Technology
    3.3.3 PerkinElmer
    3.3.3.1 PerkinElmer- Revenue Performance Analysis
    3.3.3.2 PerkinElmer Products
    3.3.4 BD (Becton, Dickinson and Company)
    3.3.4.1 BD- Revenue Performance Analysis
    3.3.4.2 Cell-Based Assays Through BD Life Sciences
    3.3.5 InSphero
    3.3.5.1 InSphero- GravityPLUS Leading Solution
    3.3.6 QGel
    3.3.6.1 QGel Products and Services
    3.3.7 Biocroi
    3.3.7.1 Biocroi- Products and Services
    3.3.8 GE Healthcare
    3.3.8.1 GE Healthcare Life Sciences: Cell-Based Assay Products
    3.3.9 Molecular Devices
    3.3.9.1 Molecular Devices: Cell-Based Assay Products- SpectraMax Microplate Readers and FLIPR Tetra System
    3.3.10 Promega
    3.3.10.1 Promega Assays Range
    3.3.11 BioVision
    3.3.11.1 BioVision: Cell-Based Assays
    3.4 Leading Companies in the Cell-Based Assays Market: CROs and Service Providers, 2016
    3.4.1 Porsolt: Acquires Fluofarma
    3.4.1.1 Fluofarma
    3.4.1.2 Fluofarma has Over 100 Cell-Based Assays
    3.4.2 CYTOO
    3.4.2.1 Cell Micropatterning to Eliminate Trade-off Between Quantity and Quality?
    3.4.2.2 Cell-Based Assays for Muscular Atrophy/Hypertrophy and Anti-Cancer Drug Profiling
    3.4.3 Cell Assay Innovations (CAI)
    3.4.3.1 ClariCELL Technology
    3.4.4 ProQinase
    3.4.4.1 ProQinase Cell-Based Assay Services, 2016
    3.4.5 Charles River Laboratories
    3.4.5.1 PhenoFocus – Portfolio of over 100 Primary Cell-Based Assays
    3.4.6 BioAgilytix
    3.4.7 SGS
    3.4.7.1 Offers a Range of Services, Including 3D Cell-Based Assays
    3.4.8 Pharmaceutical Product Development
    3.4.9 Marin Biologic Laboratories
    3.5 Mergers & Acquisitions in Cell Based Assay Market, 2015

    CHAPTER 4: GLOBAL MARKET SEGMENTATION - BY SECTOR

    4.1 Cell-Based Assays Market Segments- Products and Services
    4.2 Cell-Based Assays Market Segments: Products Forecast 2016-2026
    4.3 Cell-Based Assays Market Segments: Services Forecast 2016-2026

    CHAPTER 5: GLOBAL MARKET SEGMENTATION- BY APPLICATION

    5.1 Cell-Based Assays Market- Applications
    5.1.1 Drug Discovery Segment Forecast, 2016-2026
    5.1.2 ADME Segment Forecast 2016-2026
    5.1.3 Basic Research Segment Forecast, 2016-2026

    CHAPTER 6: CELL-BASED ASSAYS MARKET- WORLD INDUSTRY

    6.1 Cell-Based Assays Market Overview
    6.2 Cell-Based Assays Market Segmentation
    6.3 Global Cell-Based Assays Market Forecast: 2016-2026
    6.4 Products Sector of Cell-Based Assays Industry is Biggest
    6.5 Highest Revenue in Drug Discovery for Application Industry of Cell-Based Assays
    6.6 Drivers and Restraints for Cell-Based Assays Market

    CHAPTER 7: CELL-BASED ASSAYS INDUSTRY REVENUE, BY GEOGRAPHY

    7.1 National Market Overview
    7.2 Regional Cell-Based Assays Market Forecast: 2016-2026
    7.3 The US
    7.3.1 The US Cell-Based Assays Revenue Forecast 2016-2026
    7.3.2 STEP Analysis for the US Market
    7.4 Japan
    7.4.1 Japanese Cell-Based Assays Revenue Forecast, 2016-2026
    7.4.2 STEP Analysis for Japan Market
    7.5 EU5
    7.5.1 EU5 Market Forecast: 2016-2026
    7.5.2 German Cell-Based Assay Revenue Forecast, 2016-2026
    7.5.3 French Cell-Based Assays Revenue Forecast, 2016-2026
    7.5.4 UK Cell-Based Assays Revenue Forecast, 2016-2026
    7.5.5 Spanish Cell-Based Assays Revenue Forecast, 2016-2026
    7.5.6 Italian Cell-Based Assays Revenue Forecast, 2016-2026
    7.5.7 STEP Analysis for EU5 Market
    7.6 BRIC Nations
    7.6.1 BRIC Market Forecast, 2016-2026
    7.6.2 China Market Forecast, 2016-2026
    7.6.3 India Market Forecast, 2016-2026
    7.6.4 Russia Market Forecast, 2016-2026
    7.6.5 Brazil Market Forecast, 2016-2026
    7.6.6 STEP Analysis for BRIC Market

    CHAPTER 8: CELL-BASED ASSAYS TECHNOLOGY, TRENDS AND FUTURE OUTLOOK

    8.1 Stem Cells: Enormous Potential
    8.1.1 The Benefits of Using Stem Cells in Cell-Based Assays
    8.1.2 iPSCs: An Uncontroversial and Abundant Source
    8.1.3 Companies Providing Stem Cell-Based Assays
    8.2 Toxicity Testing: Important Field for Cell-Based Assays
    8.3 3D Systems: The Advantages of Next Generation of Cell Systems
    8.3.1 Complexity of 3D Systems is a Challenge but More are Reaching the Market
    8.3.2 Organoids – The Future of Drug Development?
    8.3.2.1 Hurdles to the Future Organoid Market
    8.3.2.2 Organoids Now and in the Future
    8.3.3 Bio-Printing for Drug Development: Using 3D Printing Technology
    8.4 Increasing Outsourcing of Cell-Based Assays
    8.5 Label-Free Technology
    8.6 GPCRs: A Common Drug and Drug Discovery Target
    8.6.1 GPCRs in Cell-Based Assays
    8.6.2 Allosteric GPCRs
    8.7 Increasing Miniaturisation and Automation
    8.7.1 Advantages of Miniaturisation
    8.7.2 Advantages of Automation
    8.8 Microfluids are Set to be a Trend
    8.8.1 The Potential Challenges to Microfluids
    8.9 Multiplexing: Improves Efficiency of cell-Based Assays
    8.9.1 Advantages will Drive Growth
    8.10 High Content Screening: A Well Established Tool
    8.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
    8.11 Cell-Based Assays for the Development of Biologics

    CHAPTER 9: PRICING, REIMBURSEMENT AND MARKET ACCESS

    9.1 Regulatory Hurdles and Update on Regulations – Cell-Based Assays Market
    9.1.1 US
    9.1.2 Japan
    9.1.3 EU5
    9.1.4 Emerging Markets
    9.2 Pricing, Reimbursement and Market Access –Cell-Based Assays Diseases Drugs Market
    9.2.1 US
    9.2.2 Japan
    9.2.3 EU5
    9.2.4 Emerging Markets

    CHAPTER 10: EXPERT OPINIONS

    10.1 Interview with Dr. Jan Lichtenberg, CEO and Co-Founder of InSphero

    CHAPTER 11: CELL-BASED ASSAYS MARKET CONCLUSIONS AND RECOMMENDATIONS FOR BUSINESS STRATEGIES

    11.1 Growth Has Been Driven by Advantages of Cell-Based Assays
    11.2 Current Status of the Market and its Growth Drivers
    11.3 The Most Dominant National Markets and Emerging Countries
    11.4 Future Trends and Technology
    11.5 RECOMMENDATIONS

    APPENDIX

    DART Report Evaluation FormFigure 1: Cell-Based Assays Market Segmentation by Application: Market Share (%), 2015
    Figure 2: Cell-Based Assays Market Segmentation by Sectors: Market Share (%), 2015
    Figure 3: Stages of Pre-Clinical Drug Development
    Figure 4: STEP Analysis of Cell-Based Assays Market, 2016-2026
    Figure 5: SWOT Analysis of Cell-Based Assays Market, 2016-2026
    Figure 6: ThermoFisher Scientific Historical Revenue ($bn), 2010-2015
    Figure 7: PerkinElmer Historical Revenue ($bn), 2010-2015
    Figure 8: PerkinElmer Revenue Breakdown by Segment, 2015
    Figure 9: BD Historical Revenue ($bn), 2010-2015
    Figure 10: Revenue Share (%) Breakdown of BD Life Sciences Segment, 2015
    Figure 11: Charles River Laboratories Revenue Breakdown: Revenue ($bn), 2013-2015
    Figure 12: Cell-Based Assays Market Segmented by Application
    Figure 13: Cell-Based Assays Market Forecast Segmented by Sector: Revenue ($bn), 2015-2026
    Figure 14: Products Sector Market Forecast: Revenue ($bn), 2015-2026
    Figure 15: Products Sector Market Forecast: AGR (%), 2016-2026
    Figure 16: Services Sector Market Forecast: Revenue ($bn), 2015-2026
    Figure 17: Services Sector Market Forecast: AGR (%), 2016-2026
    Figure 18: Cell-Based Assays Market Forecast Segmented by Application: Revenue ($bn), 2015-2026
    Figure 19: Drug Discovery Market Forecast: Revenue ($bn), 2015-2026
    Figure 20: Drug Discovery Market Forecast: AGR (%), 2015-2026
    Figure 21: ADME Market Forecast: Revenue ($bn), 2015-2026
    Figure 22: ADME Market Forecast: AGR (%), 2016-2026
    Figure 23: Basic Research Market Forecast: Revenue ($bn), 2015-2026
    Figure 24: Basic Research Market Forecast: AGR (%), CAGR (%), 2015-2026
    Figure 25: Cell-Based Assays Market Segmented by Application
    Figure 26: Cell-Based Assays Market Segmented by Sector
    Figure 27: Cell-Based Assays Products Market Segments
    Figure 28: Global Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 29: Global Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 30: Cell-Based Assays Market Segmentation by Sector: Market Share (%), 2015
    Figure 31: Cell-Based Assays Market Segmentation by Sector: Market Share (%), 2020
    Figure 32: Cell-Based Assays Market Segmentation by Sector: Market Share (%), 2026
    Figure 33: Cell-Based Assays Market Segmentation by Application: Market Share (%), 2015
    Figure 34: Cell-Based Assays Market Segmentation by Application: Market Share (%), 2020
    Figure 35: Cell- Based Assays Market Segmentation by Application: Market Share (%), 2026
    Figure 36: Drivers and Restraints for the Cell-Based Assays Market, 2016
    Figure 37: Cell-Based Assays Market Breakdown by Region: Market Share (%), 2015
    Figure 38: Cell-Based Assays Market Breakdown by Region: Market Share (%), 2020
    Figure 39: Cell-Based Assays Market Breakdown by Region: Market Share (%), 2026
    Figure 40: Global Cell-Based Assays Market, Regional Forecast: Revenue ($bn), 2015-2026
    Figure 41: US Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 42: US Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 43: STEP Analysis for Cell- Based Assays Market in the US, 2016-2026
    Figure 44: Japan Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 45: Japan Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 46: STEP Analysis for Cell-Based Assays Market in Japan, 2016-2026
    Figure 47: EU Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 48: EU Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 49: EU Market, Top National Forecast: Revenue ($bn), 2015-2026
    Figure 50: EU Market Breakdown by Nation: EU Market Shares (%), 2015
    Figure 51: EU Market Breakdown by Nation: EU Market Shares (%), 2020
    Figure 52: EU Market Breakdown by Nation: EU Market Share (%), 2026
    Figure 53: Germany Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 54: Germany Cell-Based Assays Market Forecasts: AGR (%), 2016-2026
    Figure 55: French Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 56: French Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 57: UK Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 58: UK Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 59: Spain Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 60: Spain Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 61: Italy Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 62: Italy Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 63: STEP Analysis for Cell-Based Assays Market in EU5, 2016-2026
    Figure 64: BRIC Market Breakdown by Nation: BRIC Market Share (%), 2015
    Figure 65: BRIC Market Breakdown by Nation: BRIC Market Share (%), 2020
    Figure 66: BRIC Market Breakdown by Nation: BRIC Market Share (%), 2026
    Figure 67: BRIC Market, Top National Forecasts: Revenue ($bn), 2016-2026
    Figure 68: China Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 69: China Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 70: India Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 71: India Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 72: Russia Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 73: Russia Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 74: Brazil Cell-Based Assays Market Forecast: Revenue ($bn), 2015-2026
    Figure 75: Brazil Cell-Based Assays Market Forecast: AGR (%), 2016-2026
    Figure 76: STEP Analysis for Cell-Based Assays Market in BRIC, 2016-2026
    Figure 77: Healthcare Expenditure and GDP for Countries, 2013
    Figure 78: The Cell-Based Assay Submarket Revenue ($bn) Breakdown by Products and Services, 2015, 2020 and 2026
    Figure 79: Cell-Based Assays Market Segmented by Sector: CAGR (%) 2015-2026
    Figure 80: The Cell-Based Assay Submarket Revenue ($bn) Breakdown by Application: Drug Discovery, ADME and Basic Research, 2015, 2020 and 2026
    Figure 81: Cell-Based Assays Market Segmented by Application: CAGR (%) 2015-2026
    Figure 82: Regional Breakdown of the Cell-Based Assay Market by Revenue ($bn), 2015, 2020 and 2026

    LIST OF FIGURES

    Figure 1: AMD and Other Retinal Diseases Drug Market Share (%), 2015
    Figure 2: STEP Analysis for Retinal Diseases Market, 2016-2026
    Figure 3: SWOT analysis of Retinal Diseases Market, 2016-2026
    Figure 4: Regeneron Historical Revenue ($bn), 2011-2015
    Figure 5: Novartis Historical Revenue ($bn), 2011-2015
    Figure 6: Novartis Revenue Share (%) by Segment, 2015
    Figure 7: Roche Historical Revenue ($bn), 2011-2015
    Figure 8: Roche Revenue Share (%) by Segment, 2015
    Figure 9: Bayer’s Pharmaceutical Segment Historical Revenue ($bn), 2011-2015
    Figure 10: Market Breakdown by Product Market Share (%), 2020
    Figure 11: Market Breakdown by Product: Market Share (%), 2026
    Figure 12: Market Forecast by Product: Revenue ($bn), 2015-2026
    Figure 13: Market Breakdown by Product: Revenue ($bn), 2015, 2020 and 2026
    Figure 14: Wet AMD Segment Forecast Revenue ($bn), 2015-2026
    Figure 15: Porter’s Five Forces Analysis for Drugs, 2015
    Figure 16: Eylea Forecast Revenue ($bn), 2015-2026
    Figure 17: Lucentis Forecast Revenue ($bn), 2015-2026
    Figure 18: Avastin Forecast Revenue ($bn), 2015-2026
    Figure 19: Visudyne Forecast Revenue ($bn), 2015-2026
    Figure 20: Jetrea Forecast Revenue ($bn), 2015-2026
    Figure 21: Dry AMD Segment Forecast Revenue ($bn), 2015-2026
    Figure 22: DR Segment Forecast Revenue ($bn), 2015-2026
    Figure 23: World AMD and Other Retinal Diseases Market Forecast Revenue ($bn), 2015-2026
    Figure 24: Market Breakdown by Disease Segment Revenues ($bn), 2015
    Figure 25: Market Breakdown by Disease Segment Market Share (%), 2015
    Figure 26: Retinal Diseases Market Breakdown by Segment Revenue ($bn), 2015, 2020 and 2026
    Figure 27: Retinal Diseases Market Breakdown by Segment Revenue ($bn), 2015-2026
    Figure 28: Market Breakdown by Disease Segment Market Share (%), 2020
    Figure 29: Market Breakdown by Disease Segment Market Share (%), 2026
    Figure 30: Market Breakdown by Products Revenue ($bn), Market Share (%), 2015
    Figure 31: Market Breakdown by Company Market Share (%), 2015
    Figure 32: Leading Causes of Blindness Worldwide, Proportion of Total (%), 2010
    Figure 33: Leading Causes of Visual Impairment (Inclusive of Blindness) Worldwide, Proportion of Total (%), 2010
    Figure 34: The National Market Share (%) of Retinal Diseases, 2015
    Figure 35: Regional Market Breakdown Revenue ($bn), 2015, 2020 and 2026
    Figure 36: The National Market Share (%) of Retinal Diseases, 2020
    Figure 37: The National Market Share (%) of Retinal Diseases, 2026
    Figure 38: US Retinal Diseases Market Forecast Revenue ($bn), 2015-2026
    Figure 39: STEP Analysis for Retinal Diseases Market in the US, 2016-2026
    Figure 40: Japan Retinal Diseases Market Forecast Revenue ($bn), 2015-2026
    Figure 41: STEP Analysis for Retinal Diseases Market in Japan, 2016-2026
    Figure 42: EU5 Retinal Diseases Market Share (%) Forecast, 2015, 2020 and 2026
    Figure 43: EU5 Retinal Diseases Market Forecast Revenue ($bn), 2015-2026
    Figure 44: Germany Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 45: France Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 46: Italy Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 47: UK Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 48: Spain Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 49: STEP Analysis for Retinal Diseases Market in EU5, 2016-2026
    Figure 50: BRIC Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 51: BRIC Retinal Diseases Market Share (%) Forecast, 2015, 2020 and 2026
    Figure 52: China Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 53: India Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 54: Brazil Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 55: Russia Retinal Diseases Market Revenue ($bn) Forecast, 2015-2026
    Figure 56: STEP Analysis for Retinal Diseases Market in BRIC, 2016-2026
    Figure 57: Healthcare Expenditure and GDP For Countries, 2013
    Figure 58: National Market CAGR (%), 2015-2026
    Figure 59: Retinal Diseases Drugs Revenue ($bn), 2015
    Figure 60: Retinal Market Segments CAGR (%), 2015-2026

    LIST OF TABLES

    Table 1: Global Cell-Based Assays Market Regional Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 2: Main Parameters Required in Drug Discovery and Development
    Table 3: Selected Label-Free Detection Technologies Used for Cell-Based Assays, 2016
    Table 4: Cell-Based Assays for HTS in Drug Screening, 2016
    Table 5: Life Technologies Cell-Based Assay Technology Overview, 2016
    Table 6: Life Technologies Cell-Based Assay Technology Overview, 2016
    Table 7: Other DiscoveRx Assay Platforms, 2016
    Table 8: QGel Products and Services Cell-Based Assay Products, 2016
    Table 9: GE Healthcare Life Sciences Cell-Based Assay Products, 2016
    Table 10: ProQinase Cell-Based Assay Services, 2016
    Table 11: Charles River Laboratories Revenue Breakdown: Revenue ($bn), 2013-2015
    Table 12: Charles River Laboratories Revenue Breakdown: Revenue ($bn), 2013-2015
    Table 13: Cell-Based Assays Market Breakdown Forecast by Sector: Revenue ($bn), AGR (%), CAGR (%), Market Shares (%), 2015-2026
    Table 14: Products Sector Market Forecast: Revenue ($bn), AGR (%), CAGR (%) and Market Shares (%), 2015-2026
    Table 15: Services Sector Market Forecast: Revenue ($bn), AGR (%), CAGR (%) and Market Share (%), 2015-2026
    Table 16: Cell-Based Assays Market Forecast Breakdown by Application: Revenue ($bn), Market Share (%), 2015-2026
    Table 17: Drug Discovery Market Forecast: Revenue ($bn), AGR (%), CAGR (%) and Market Share (%), 2015-2026
    Table 18: ADME Market Forecast: Revenue ($bn), AGR (%), CAGR (%) and Market Share (%), 2015-2026
    Table 19: Basic Research Market Forecast: Revenue ($bn), AGR (%), CAGR (%) and Market Share (%), 2015-2026
    Table 20: Global Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
    Table 21: Cell-Based Assays Market Breakdown by Sector: Market Share (%), 2015, 2020 and 2026
    Table 22: Cell-Based Assays Market Breakdown by Application: Market Shares (%), 2015, 2020 and 2026
    Table 23: Cell-Based Assays Market Breakdown by Region: Revenue ($bn), Market Share (%), 2015
    Table 24: Cell-Based Assays Market Breakdown by Region: Revenue ($bn), Market Share (%), 2020
    Table 25: Cell-Based Assays Market Breakdown by Region: Revenue ($bn), Market Share (%), 2026
    Table 26: Global Cell-Based Assays Market Regional Forecasts: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 27: US Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 28: Japan Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 29: EU Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 30: EU Cell-Based Assays Market, Leading Five National Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 31: EU Market Breakdown by Leading Nation: EU Market Share (%), Global Market Share (%) and Revenue ($bn), 2015
    Table 32: EU Market Breakdown by Leading Nation: EU Market Share (%), Global Market Share (%) and Revenue ($bn), 2020
    Table 33: EU Market Breakdown by Leading Nation: EU Market Share (%), Global Market Share (%) and Revenue ($bn), 2026
    Table 34: Germany Cell-Based Assays Market Forecasts: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 35: French Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 36: UK Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 37: Spain Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 38: Italy Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 39: BRIC Market Breakdown: BRIC Market Share (%), Global Market Share (%) and Revenue ($bn), 2015
    Table 40: BRIC Market Breakdown: BRIC Market Share (%), Global Market Share (%) and Revenue ($bn), 2020
    Table 41: BRIC Market Breakdown: BRIC Market Share (%), Global Market Share (%) and Revenue ($bn), 2026
    Table 42: BRIC Cell-Based Assays Market, Leading Five National Forecast: Revenue ($bn), AGR (%), CAGR (%), Market Share (%), 2015-2026
    Table 43: China Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 44: India Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 45: Russia Cell-Based Assays Market Forecast: Revenue ($bn), AGR (%), CAGR (%), Global Market Share (%), 2015-2026
    Table 46: Brazil Cell-Based Assays Market Forecasts: Revenue ($bn), AGR (%), CAGR (%),Global Market Share (%), 2015-2026
    Table 47: Selected Companies with Involvement in Stem Cell-Based Assays, 2016
    Table 48: Selected Companies Offering Label-Free Assay Systems, 2016
  • Affymetrix
    Alliance Regenerative Medicine
    AstraZeneca
    ATCC
    Axiogenesis
    Bayer
    BBC (British Broadcasting Corporation)
    BD (Becton, Dickinson and Company)
    Bio-Rad
    BioAgilytix
    BioCity
    Biocroi
    Biofocus
    BioSeek
    BioVision
    BMG Labtech
    CareFusion Corporation
    Cell Assay Innovations (CAI)
    Cellartis (Takara Bio)
    Cellomics
    Cellular Dynamics
    Charles River Laboratories
    Corning
    Covance
    CXR Biosciences
    Cyprotex
    Cytek
    CYTOO
    Di Carlo Laboratory
    DiscoveRx
    Dr. Reddy’s Laboratories
    ESI BIO (BioTime)
    European Lead Factory
    Eurostars
    Evotec
    Fisher Scientific
    Fluofarma
    ForteBio
    Foundation Top Institute Pharma
    GE Healthcare
    GenCell
    General Electric (GE)
    Harlan Laboratories
    Hubrecht Institute
    Imagen Biotech
    InSphero
    Janssen
    Japan Institute of Biomedical Research
    Jubilant Biosys
    Lead Discovery Centre GmbH
    Life Technologies Corporation
    Marin Biologic Laboratories
    Maxcyte
    Merck & Co.
    Molecular Devices
    Netherlands Cancer Institute
    OcellO
    Organovo
    PerkinElmer
    Pharmaceutical Product Development (PPD)
    Pharmacyclics
    PharmaTimes
    Princeton University
    Promega
    ProQinase
    QGel
    Quintiles
    ReNeuron
    ReproCELL
    Roche
    Sanofi
    Seahorse Bioscience
    SGS (Société Générale de Surveillance)
    Solvo
    SRU Biosystems
    Swiss Federal Institute of Technology
    SymCel
    Syncom
    The European Lead Factory (ELF)
    The Innovative Medicines Initiative (IMI)
    The National Health Service (NHS)
    The Netherlands Cancer Institute
    The Scientist Magazine
    Thermo Electron
    Thermo Fisher Scientific
    Trinity College, Dublin
    Tufts Center for the Study of Drug Development
    UCB (Union Chimique Belge)
    UCLA (University of California, Los Angeles)
    UK Department of Health
    University of Kyoto
    University of Oxford
    University of Zurich
    US Congress
    US FDA
    Vala Sciences
    WuXi
  • Single User Licence
    £3800
    Departmental Licence
    £4900
    Site Licence
    £5999
    Global Licence
    £7999

    Single User License: This license allows for use of a report by one named person, explicitly confirmed at point of sale. This person may use the report but may not share the report (or any information contained therein) with any other person or persons. Unless a Departmental License, a Site License or a Global Site License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same enterprise. The license is valid for 12 months from the date the report is sent.

    Departmental Licenses: This license allows for use of a report by six people within the same enterprise location. You may print a copy of the report under each user. Each of these people may use the report but may not share the report (or any information contained therein) with any other person or persons. DART provides a service whereby we print, bind and ship a hard copy report for you, in full colour. But this service is only available for clients who purchase a departmental licence or above. The license is valid for 12 months from the date the report is sent.

    Site License: This license allows for use of a report by an unlimited number of people within the same enterprise location. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any person or persons outside of the enterprise location. There is no time limit access to the report.

    Global License: This license allows for use of a report by an unlimited number of people within the same enterprise worldwide. Each of these people may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise. Datasets refers to the Excel spread sheets that we have formulated and which details the global, regional/national and submarket data as shown within our reports. There is no time limit access to the report.

Copyright © DART Markets. All rights reserved.

Cookie policy

We use cookies on our website. By using our website you agree to this Policy and you consent to our use of cookies in accordance with the terms of this Policy.

About Cookies
A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

There are two main kinds of cookies: "session" cookies and "persistent" cookies. Session cookies only last for the duration of users using the website and are deleted from your computer when you close your browser, whereas persistent cookies outlast user sessions and remain stored on your computer until deleted, or until they reach their expiry date.

Cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not.

Cookies do not contain any information that personally identifies you, a cookie in no way gives us access to your computer or any information about you.

You can choose to accept or decline cookies. Most web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. This may prevent you from taking full advantage of the website.

Cookies on this Website
We use persistent cookies on this website to provide links to social network sharing services, and to update you on our most popular content.

Third Party Cookies
We do not use third party cookies.

Google Analytics
We also use cookies to help us improve the website's usability and for marketing purposes. We may also use cookies to identify which pages are being used. This helps us analyse data about webpage traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes and then the data is removed from the system.

For this purpose we use Google Analytics. Google Analytics generates statistical and other information about website use by means of cookies, which are stored on users' computers. The information generated relating to our website is used to create reports about the use of the website. Google will store and use this information. Google's privacy policy is available at www.google.com/privacypolicy.html.

This website cookies policy template is based on a free document supplied by The Legal Stop Limited through its website www.thelegalstop.co.uk.

If you have any questions about privacy please contact us.